Clinical Controlled Trial on Extinction of Opioidergic Binge Eating Disorder (BED) With Intranasal Naloxone Administration

Trial Profile

Clinical Controlled Trial on Extinction of Opioidergic Binge Eating Disorder (BED) With Intranasal Naloxone Administration

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2017

At a glance

  • Drugs Naloxone (Primary)
  • Indications Binge-Eating Disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jun 2017 According to an Opiant Pharmaceuticals media release, the study results are expected to be independently published in a scientific journal.
    • 27 Mar 2013 Results will be presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 03 May 2012 Primary endpoint 'Binge-frequency' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top